Glenmark Pharmaceuticals Ltd.
GLENMARKHealthcareR1 raw held document library
Coverage
| Dataset | On disk | Usable | State |
|---|---|---|---|
| Results XBRL (NSE + BSE) | 103 | 33 | 33 quarter-ends |
| Annual reports | 11 | 11 | identity graded |
| Earnings calls | 17 | 0 | transcripts and analyst meets only |
| Shareholding | 21 | 21 | |
| Related party | 5 | 5 | |
| Investor decks | 0 | 0 | cohort of 48 companies only |
Financial statements in parse — expected 19 Sep 2026. Nothing from the superseded legacy store is shown.
Earnings calls
17 transcript(s)/analyst meet(s) served; 17 document(s) on file are not transcripts (cover letters, duplicates, unresolved) and are excluded. Speaker attribution is shown only where the segmenter attributes ≥ 95% of sentences to management or analysts (0 of 17 documents here); elsewhere sentences render unattributed.
| Kind | Date | Period | Served | Attribution rate |
|---|---|---|---|---|
| COVER_LETTER | 20220603 | 2022-03-31 | no | |
| COVER_LETTER | 20220817 | 2022-06-30 | no | |
| COVER_LETTER | 20221118 | 2022-09-30 | no | |
| COVER_LETTER | 20230215 | 2022-12-31 | no | |
| COVER_LETTER | 20230525 | 2023-03-31 | no | |
| COVER_LETTER | 20230821 | 2023-06-30 | no | |
| COVER_LETTER | 20231120 | 2023-09-30 | no | |
| COVER_LETTER | 20240219 | 2023-12-31 | no | |
| COVER_LETTER | 20240529 | 2024-03-31 | no | |
| COVER_LETTER | 20240820 | 2024-06-30 | no | |
| COVER_LETTER | 20241121 | 2024-09-30 | no | |
| COVER_LETTER | 20250219 | 2024-12-31 | no | |
| COVER_LETTER | 20250527 | 2025-03-31 | no | |
| COVER_LETTER | 20251119 | 2025-09-30 | no | |
| COVER_LETTER | 20260204 | 2025-12-31 | no | |
| COVER_LETTER | 20260605 | 2026-03-31 | no | |
| COVER_LETTER | 20260805 | 2026-06-30 | no |